Most read article(s)

  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
    Vineet Joag, Sathi Wijeyesinghe, J. Michael Stolley, Clare F. Quarnstrom, Thamotharampillai Dileepan, Andrew G. Soerens, Jules A. Sangala, Stephen D. O’Flanagan, Noah V. Gavil, Sung-Wook Hong, Siddheshvar Bhela, Sailaja Gangadhara, Eyob Weyu, William E. Matchett, Joshua Thiede, Venkatramana Krishna, Maxim C.-J. Cheeran, Tyler D. Bold, Rama Amara, Peter Southern, Geoffrey T. Hart, Luca Schifanella, Vaiva Vezys, Marc K. Jenkins, Ryan A. Langlois and David Masopust
    J Immunol 206 (5) 931-935; March 1, 2021, doi: https://doi.org/10.4049/jimmunol.2001400
  • Natural and Induced Tolerogenic Dendritic Cells
    Courtney A. Iberg and Daniel Hawiger
    J Immunol 204 (4) 733-744; February 15, 2020, doi: https://doi.org/10.4049/jimmunol.1901121
  • Influenza Virus and SARS-CoV-2 Vaccines
    Adam M. Sandor, Michael S. Sturdivant and Jenny P. Y. Ting
    J Immunol 206 (11) 2509-2520; June 1, 2021, doi: https://doi.org/10.4049/jimmunol.2001287
  • Comparative Analysis of Antigen-Specific Anti–SARS-CoV-2 Antibody Isotypes in COVID-19 Patients
    Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Kenya Yamase, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Yohei Doi and Kuniaki Saito
    J Immunol 206 (10) 2393-2401; May 15, 2021, doi: https://doi.org/10.4049/jimmunol.2001369
  • Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
    Erik H. Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar-de Heer, Gerard van Mierlo, Federica Linty, Juk Yee Mok, Wim van Esch, Sanne de Bruin, Alexander P. J. Vlaar, Amsterdam University Medical Center COVID-19 Biobank Study Group,2, Bart Seppen, Maureen Leeuw, Anne J. G. van Oudheusden, Anton G. M. Buiting, Kin Ki Jim, Hans Vrielink, Francis Swaneveld, Gestur Vidarsson, C. Ellen van der Schoot, Peter C. Wever, Wentao Li, Frank van Kuppeveld, Jean-Luc Murk, Berend Jan Bosch, Gerrit-Jan Wolbink and Theo Rispens
    J Immunol 205 (12) 3491-3499; December 15, 2020, doi: https://doi.org/10.4049/jimmunol.2000767
  • Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
    William E. Matchett, Vineet Joag, J. Michael Stolley, Frances K. Shepherd, Clare F. Quarnstrom, Clayton K. Mickelson, Sathi Wijeyesinghe, Andrew G. Soerens, Samuel Becker, Joshua M. Thiede, Eyob Weyu, Stephen D. O’Flanagan, Jennifer A. Walter, Michelle N. Vu, Vineet D. Menachery, Tyler D. Bold, Vaiva Vezys, Marc K. Jenkins, Ryan A. Langlois and David Masopust
    J Immunol 207 (2) 376-379; July 15, 2021, doi: https://doi.org/10.4049/jimmunol.2100421
  • Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
    Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, Ashley F. George, Julie Frouard, Victoria Murray, Gurjot Gill, Eliver Ghosn, Evan W. Newell, Sulggi A. Lee and Nadia R. Roan
    J Immunol 207 (5) 1344-1356; September 1, 2021, doi: https://doi.org/10.4049/jimmunol.2100465
  • COVID-19: Complement, Coagulation, and Collateral Damage
    Martin W. Lo, Claudia Kemper and Trent M. Woodruff
    J Immunol 205 (6) 1488-1495; September 15, 2020, doi: https://doi.org/10.4049/jimmunol.2000644
  • Coronavirus Receptors as Immune Modulators
    Charan Kumar V. Devarakonda, Emily Meredith, Mallika Ghosh and Linda H. Shapiro
    J Immunol 206 (5) 923-929; March 1, 2021, doi: https://doi.org/10.4049/jimmunol.2001062
  • Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
    Simone Nüssing, Imran G. House, Conor J. Kearney, Amanda X. Y. Chen, Stephin J. Vervoort, Paul A. Beavis, Jane Oliaro, Ricky W. Johnstone, Joseph A. Trapani and Ian A. Parish
    J Immunol 204 (8) 2308-2315; April 15, 2020, doi: https://doi.org/10.4049/jimmunol.1901396

Pages